Table 1.
Correlations between ACP5 expression and clinicopathologic features in 285 colorectal cancer patients
| Clinicopathological feature | Total 285 | ACP5 expression | P value (χ2 test) | |
|---|---|---|---|---|
|
| ||||
| Low (n=113, 39.65%) | High (n=172, 60.35%) | |||
| Age (years) | ||||
| < 65 | 122 | 47 (41.59) | 75 (43.60) | 0.737 |
| ≥ 65 | 163 | 66 (58.41) | 97 (56.40) | |
| Gender | ||||
| Male | 170 | 69 (61.06) | 101 (58.72) | 0.694 |
| Female | 115 | 44 (38.94) | 71 (41.28) | |
| Tumor location | ||||
| Rectum | 176 | 73 (64.60) | 103 (59.88) | 0.423 |
| Colon | 109 | 40 (35.40) | 69 (40.12) | |
| Tumor size | ||||
| ≤ 5 cm | 149 | 68 (60.18) | 81 (47.09) | 0.031 |
| > 5 cm | 136 | 45 (39.82) | 91 (52.91) | |
| CEA level | ||||
| ≤ 5 ng/ml | 141 | 59 (52.21) | 82 (47.67) | 0.454 |
| > 5 ng/ml | 144 | 54 (47.79) | 90 (52.33) | |
| Tumor classification | ||||
| T1-2 | 92 | 45 (39.82) | 47 (27.33) | 0.027 |
| T3-4 | 193 | 68 (60.18) | 125 (72.67) | |
| Lymph node metastasis | ||||
| Absent | 144 | 71 (62.83) | 73 (42.44) | 0.001 |
| Present | 141 | 42 (37.17) | 99 (57.56) | |
| Distant metastasis | ||||
| Absent | 233 | 102 (90.27) | 131 (76.16) | 0.003 |
| Present | 52 | 11 (9.73) | 41 (23.84) | |
| TNM stage(AJCC) | ||||
| Stage I | 85 | 44 (38.94) | 41 (23.84) | 0.005 |
| Stage II | 59 | 24 (21.24) | 35 (20.34) | |
| Stage III | 89 | 34 (30.09) | 55 (31.98) | |
| Stage IV | 52 | 11 (9.73) | 41 (23.84) | |
Values in parentheses indicate percentage values. The bold number represents the P-values with significant differences.